-
T.
Senderovitz,
J.
Vestbo,
J.
Frandsen,
N.
Maltbæk,
M.
Nørgaard,
C.
Nielsen,
J.
Kampmann
(1999)
Steroid reversibility test followed by inhaled budesonide or placebo in outpatients with stable chronic obstructive pulmonary disease. The Danish Society of Respiratory Medicine.
Respiratory medicine, 93 10
-
D.
Mahler,
P.
Wire,
D.
Horstman,
Chai-Ni
Chang,
J.
Yates,
Tracy
Fischer,
T.
Shah
(2002)
Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary disease.
American journal of respiratory and critical care medicine, 166 8
-
H.
Kerstjens,
D.
Postma
(2002)
[Medical maintenance treatment of chronic obstructive pulmonary disease (COPD)].
Nederlands tijdschrift voor geneeskunde, 146 35
-
ER
Sutherland
(2003)
Inhaled corticosteroids reduce the progression of airflow limitation in COPD: a meta-analysis
Thorax, 58
-
P.
Barnes
(2000)
Chronic obstructive pulmonary disease.
The New England journal of medicine, 343 4
-
T.
Renkema,
J.
Schouten,
G.
Köeter,
D.
Postma
(1996)
Effects of long-term treatment with corticosteroids in COPD.
Chest, 109 5
-
P.
Grunsven,
C.
Schayck,
J.
Derenne,
H.
Kerstjens,
T.
Renkema,
D.
Postma,
T.
Similowski,
R.
Akkermans,
P.
Jong,
P.
Dekhuijzen,
C.
Herwaarden,
C.
Weel
(1999)
Long term effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a meta-analysis
Thorax, 54
-
H.
Kerstjens,
P.
Brand,
M.
Hughes,
N.
Robinson,
D.
Postma,
H.
Sluiter,
E.
Bleecker,
P.
Dekhuijzen,
P.
Jong,
H.
Mengelers,
S.
Overbeek,
D.
Schoonbrood
(1992)
A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. Dutch Chronic Non-Specific Lung Disease Study Group.
The New England journal of medicine, 327 20
-
M.
Roth,
Peter
Johnson,
J.
Rüdiger,
G.
King,
J.
Black
(2002)
Interaction between glucocorticoids and β2 agonists on bronchial airway smooth muscle cells through synchronised cellular signalling
The Lancet, 360
-
S.
Culpitt,
W.
Maziak,
S.
Loukidis,
J.
Nightingale,
J.
Matthews,
P.
Barnes
(1999)
Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease.
American journal of respiratory and critical care medicine, 160 5 Pt 1
-
J.
Soriano,
J.
Vestbo,
N.
Pride,
V.
Kiri,
C.
Maden,
W.
Maier
(2002)
Survival in COPD patients after regular use of fluticasone propionate and salmeterol in general practice
European Respiratory Journal, 20
-
P.
Chanez,
A.
Vignola,
T.
O'Shaugnessy,
I.
Enander,
D.
Li,
P.
Jeffery,
J.
Bousquet
(1997)
Corticosteroid reversibility in COPD is related to features of asthma.
American journal of respiratory and critical care medicine, 155 5
-
P.
Jones,
L.
Willits,
P.
Burge,
P.
Calverley
(2003)
Disease severity and the effect of fluticasone propionate on chronic obstructive pulmonary disease exacerbations
European Respiratory Journal, 21
-
S.
Rutgers,
G.
Köeter,
T.
Mark,
D.
Postma
(1998)
Short-term treatment with budesonide does not improve hyperresponsiveness to adenosine 5'-monophosphate in COPD.
American journal of respiratory and critical care medicine, 157 3 Pt 1
-
S.
Korn,
A.
Jerre,
R.
Brattsand,
Inflammatory
Pharmacology,
Astra-Zeneca
Lund,
Sweden
(2001)
Effects of formoterol and budesonide on GM-CSF and IL-8 secretion by triggered human bronchial epithelial cells.
The European respiratory journal, 17 6
-
R.
Geijer,
C.
Schayck,
C.
Weel,
A.
Sachs,
A.
Zwan,
B.
Bottema,
I.
Smeele,
H.
Thiadens,
W.
Hensbergen,
C.F.H.
Rosmalen
(1997)
NHG Standaard COPD: Behandeling
Huisarts En Wetenschap, 40
-
R.
Pauwels,
C.
Löfdahl,
L.
Laitinen,
J.
Schouten,
D.
Postma,
N.
Pride,
S.
Ohlsson
(1999)
Long-Term Treatment with Inhaled Budesonide in Persons with Mild Chronic Obstructive Pulmonary Disease Who Continue Smoking
The New England Journal of Medicine, 340
-
O.
Eickelberg,
M.
Roth,
Rainer
Lörx,
Victoria
Bruce,
J.
Rüdiger,
Malcolm
Johnson,
L.
Block
(1999)
Ligand-independent Activation of the Glucocorticoid Receptor by β2-Adrenergic Receptor Agonists in Primary Human Lung Fibroblasts and Vascular Smooth Muscle Cells*
The Journal of Biological Chemistry, 274
-
N.
Jarad,
J.
Wedzicha,
P.
Burge,
P.
Calverley
(1999)
An observational study of inhaled corticosteroid withdrawal in stable chronic obstructive pulmonary disease. ISOLDE Study Group.
Respiratory medicine, 93 3
-
M.
Confalonieri,
E.
Mainardi,
R.
Porta,
S.
Bernorio,
L.
Gandola,
B.
Beghé,
A.
Spanevello
(1998)
Inhaled corticosteroids reduce neutrophilic bronchial inflammation in patients with chronic obstructive pulmonary disease
Thorax, 53
-
R.
Pauwels,
A.
Buist,
P.
Calverley,
C.
Jenkins,
S.
Hurd
(2001)
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.
American journal of respiratory and critical care medicine, 163 5
-
P.
Calverley,
R.
Pauwels,
J.
Vestbo,
P.
Jones,
N.
Pride,
A.
Gulsvik,
Julie
Anderson,
C.
Maden
(2003)
Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial
The Lancet, 361
-
S.
Culpitt,
D.
Rogers,
P.
Shah,
C.
Matos,
R.
Russell,
L.
Donnelly,
P.
Barnes
(2003)
Impaired inhibition by dexamethasone of cytokine release by alveolar macrophages from patients with chronic obstructive pulmonary disease.
American journal of respiratory and critical care medicine, 167 1
-
I.
Ferreira,
M.
Hazari,
C.
Gutierrez,
N.
Zamel,
K.
Chapman
(2001)
Exhaled nitric oxide and hydrogen peroxide in patients with chronic obstructive pulmonary disease: effects of inhaled beclomethasone.
American journal of respiratory and critical care medicine, 164 6
-
W.
Beurden,
G.
Harff,
P.
Dekhuijzen,
S.M.
Poel-Smet,
F.
Smeenk
(2003)
Effects of Inhaled Corticosteroids with Different Lung Deposition on Exhaled Hydrogen Peroxide in Stable COPD Patients
Respiration, 70
-
F.
Spoelstra,
D.
Postma,
H.
Hovenga,
J.
Noordhoek,
H.
Kauffman
(2002)
Additive anti-inflammatory effect of formoterol and budesonide on human lung fibroblasts
Thorax, 57
-
K.
Ansarin,
J.
Chatkin,
I.
Ferreira,
C.
Gutierrez,
N.
Zamel,
K.
Chapman
(2001)
Exhaled nitric oxide in chronic obstructive pulmonary disease: relationship to pulmonary function.
The European respiratory journal, 17 5
-
P.
Dekhuijzen,
K.
Aben,
I.
Dekker,
L.
Aarts,
P.
Wielders,
C.
Herwaarden,
A.
Bast
(1996)
Increased exhalation of hydrogen peroxide in patients with stable and unstable chronic obstructive pulmonary disease.
American journal of respiratory and critical care medicine, 154 3 Pt 1
-
W.
Maziak,
S.
Loukides,
S.
Culpitt,
P.
Sullivan,
S.
Kharitonov,
P.
Barnes
(1998)
Exhaled nitric oxide in chronic obstructive pulmonary disease.
American journal of respiratory and critical care medicine, 157 3 Pt 1
-
Calverley
Pm
(2000)
Inhaled corticosteroids are beneficial in chronic obstructive pulmonary disease.
American journal of respiratory and critical care medicine, 161 2 Pt 1
-
O.
Johnell,
R.
Pauwels,
C.
Löfdahl,
L.
Laitinen,
D.
Postma,
N.
Pride,
S.
Ohlsson
(2002)
Bone mineral density in patients with chronic obstructive pulmonary disease treated with budesonide Turbuhaler®
European Respiratory Journal, 19
-
R.
Wise,
J.
Connett,
G.
Weinmann,
P.
Scanlon,
M.
Skeans
(2000)
Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease.
The New England journal of medicine, 343 26
-
D.
Sin,
J.
Tu
(2001)
Inhaled corticosteroids and the risk of mortality and readmission in elderly patients with chronic obstructive pulmonary disease.
American journal of respiratory and critical care medicine, 164 4
-
L.
Meagher,
J.
Cousin,
J.
Seckl,
C.
Haslett
(1996)
Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes.
Journal of immunology, 156 11
-
K.
Hattotuwa,
M.
Gizycki,
T.
Ansari,
P.
Jeffery,
N.
Barnes
(2002)
The effects of inhaled fluticasone on airway inflammation in chronic obstructive pulmonary disease: a double-blind, placebo-controlled biopsy study.
American journal of respiratory and critical care medicine, 165 12
-
KB
Higland
(2003)
Long-term effects of inhaled corticosteroids on FEV1 in patients with COPD. A meta-analysis
Ann Intern Med, 138
-
N.
Siafakas,
P.
Vermeire,
N.
Pride,
P.
Paoletti,
J.
Gibson,
P.
Howard,
J.
Yernault,
M.
Decramer,
T.
Higenbottam,
D.
Postma
(1995)
Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force.
The European respiratory journal, 8 8
-
C.L.A.
Herwaarden,
P.
Dekhuijzen,
C.
Schayck,
C.
Weel,
J.
Molema
(1996)
De medicamenteuze behandeling van chronisch obstructieve longziekte
Nederlands Tijdschrift voor Geneeskunde, 140
-
Aidan
O'Brien,
Patricia
Russo-Magno,
Arjun
Karki,
S.
Hiranniramol,
Marquette
Hardin,
Maryann
Kaszuba,
Charles
Sherman,
Sharon
Rounds
(2001)
Effects of withdrawal of inhaled steroids in men with severe irreversible airflow obstruction.
American journal of respiratory and critical care medicine, 164 3
-
P.
Burge,
P.
Calverley,
P.
Jones,
S.
Spencer,
Julie
Anderson,
TK
Maslen
(2000)
Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial
BMJ : British Medical Journal, 320
-
P.
Jones,
F.
Quirk,
C.
Baveystock,
P.
Littlejohns
(1992)
A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire.
The American review of respiratory disease, 145 6
-
Austin
Thompson,
Mary
Mueller,
A.
Heires,
Tamara
Bohling,
D.
Daughton,
Steven
Yancey,
R.
Sykes,
S.
Rennard
(1992)
Aerosolized beclomethasone in chronic bronchitis. Improved pulmonary function and diminished airway inflammation.
The American review of respiratory disease, 146 2
-
W.
Szafrański,
A.
Cukier,
A.
RamÃrez,
G.
Menga,
R.
Sansores,
S.
Nahabedian,
S.
Peterson,
H.
Olsson
(2003)
Efficacy and safety of budesonide/formoterol in the management of chronic obstructive pulmonary disease
European Respiratory Journal, 21
-
G.
Donaldson,
T.
Seemungal,
A.
Bhowmik,
J.
Wedzicha
(2002)
Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease
Thorax, 57
-
V.
Keatings,
A.
Jatakanon,
Y.
Worsdell,
P.
Barnes
(1997)
Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD.
American journal of respiratory and critical care medicine, 155 2
-
(1987)
Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986.
The American review of respiratory disease, 136 1
-
J.
Vestbo,
Torben
Søorensen,
P.
Lange,
A.
Brix,
P.
Torre,
K.
Viskum
(1999)
Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial
The Lancet, 353
-
T.
Seemungal,
G.
Donaldson,
E.
Paul,
J.
Bestall,
D.
Jeffries,
J.
Wedzicha
(1998)
Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease.
American journal of respiratory and critical care medicine, 157 5 Pt 1
-
P.
Paggiaro,
R.
Dahle,
I.
Bakran,
L.
Frith,
K.
Hollingworth,
J.
Efthimiou
(1998)
Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease
The Lancet, 351
-
P.
Valk,
E.
Monninkhof,
J.
Palen,
G.
Zielhuis,
C.
Herwaarden
(2002)
Effect of discontinuation of inhaled corticosteroids in patients with chronic obstructive pulmonary disease: the COPE study.
American journal of respiratory and critical care medicine, 166 10
-
A.
Alsaeedi,
D.
Sin,
F.
McAlister
(2002)
The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review of randomized placebo-controlled trials.
The American journal of medicine, 113 1